ThermoGenesis Reports Third Quarter Fiscal 2013 Results
Revenues From Core Business Increase $700,000 or 19%
May 14, 2013 ,
....
"A key event during the quarter was the addition of Crioestaminal, a leading cord blood stem cell bank in Portugal, as a customer for our AXP System. They are a major European cord blood bank and we are replacing a competitor's automated system there. This customer win demonstrates the value of our integrated distribution strategy in Europe and we hope to announce other new customers in the region in the near future," Plavan noted.
- - -
Crioestaminal is a biotechnology company founded in Coimbra, Portugal in 2003, and headquartered in Cantanhede. The company's main activity is collection, and cryopreservation of cord blood stem cells. These cells may be used in therapeutical procedures directed towards several diseases. Besides stem cell cryopreservation, Crioestaminal is involved in several research projects aimed at expanding the field of application of stem cell in partnership with the Instituto de Medicina Molecular (University of Lisbon), the Instituto Português de Oncologia, the Instituto Superior Técnico (Technical University of Lisbon)
The company was founded in 2003 in Coimbra, Portugal, by young entrepreneurs with an academic background ranging from biochemistry to economics, as a Portuguese franchise of Belgium-based company Cryo-Save